IMNN ▼ -4.1% - Imunon, Inc. $IMNN - IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan 24-SEP-2026 08:05 AM ET